Hemoglobin Hiroshima (β¹⁴³ histidine → aspartic acid): a newly identified fast moving beta chain variant associated with increased oxygen affinity and compensatory erythremia

^{Department of Clinical Laboratories, Atomic Bomb Casualty Commission,* Hiroshima, Japan*}

^{Department of Clinical Pathology, Kawasaki Hospital, Okayama, Japan}

^{Third Division of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan}

^* The Commission is a cooperative research agency of the U. S. A. National Academy of Sciences—National Research Council, and the Japanese National Institute of Health of the Ministry of Health and Welfare, with funds provided by the United States Atomic Energy Commission, the Japanese Institute of Health, and the U. S. Public Health Service.

Find articles by Hamilton, H. in: PubMed | Google Scholar

^{Department of Clinical Laboratories, Atomic Bomb Casualty Commission,* Hiroshima, Japan*}

^{Department of Clinical Pathology, Kawasaki Hospital, Okayama, Japan}

^{Third Division of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan}

^* The Commission is a cooperative research agency of the U. S. A. National Academy of Sciences—National Research Council, and the Japanese National Institute of Health of the Ministry of Health and Welfare, with funds provided by the United States Atomic Energy Commission, the Japanese Institute of Health, and the U. S. Public Health Service.

Find articles by Iuchi, I. in: PubMed | Google Scholar

^{Department of Clinical Laboratories, Atomic Bomb Casualty Commission,* Hiroshima, Japan*}

^{Department of Clinical Pathology, Kawasaki Hospital, Okayama, Japan}

^{Third Division of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan}

^* The Commission is a cooperative research agency of the U. S. A. National Academy of Sciences—National Research Council, and the Japanese National Institute of Health of the Ministry of Health and Welfare, with funds provided by the United States Atomic Energy Commission, the Japanese Institute of Health, and the U. S. Public Health Service.

Find articles by Miyaji, T. in: PubMed | Google Scholar

^{Department of Clinical Laboratories, Atomic Bomb Casualty Commission,* Hiroshima, Japan*}

^{Department of Clinical Pathology, Kawasaki Hospital, Okayama, Japan}

^{Third Division of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan}

^* The Commission is a cooperative research agency of the U. S. A. National Academy of Sciences—National Research Council, and the Japanese National Institute of Health of the Ministry of Health and Welfare, with funds provided by the United States Atomic Energy Commission, the Japanese Institute of Health, and the U. S. Public Health Service.

Find articles by Shibata, S. in: PubMed | Google Scholar